http://orcid.org/0000-0001-9050-7080
Citations (36)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Susanne B Haga, Rachel Mills, Jivan Moaddeb, Yiling Liu & Deepak Voora. (2021) Independent Community Pharmacists’ Experience in Offering Pharmacogenetic Testing. Pharmacogenomics and Personalized Medicine 14, pages 877-886.
Read now
Read now
Shirley Sun & Ann Hui Ching. (2021) Social Systems Matter: Precision Medicine, Public Health, and the Medical Model. East Asian Science, Technology and Society: An International Journal 15:4, pages 439-466.
Read now
Read now
Shirley Sun. (2020) Clinical usefulness of genetic testing for drug toxicity in cancer care: decision-makers’ framing, knowledge and perceptions. New Genetics and Society 39:4, pages 359-384.
Read now
Read now
Jyothsna Giri, Ann M Moyer, Suzette J Bielinski & Pedro J Caraballo. (2019) Concepts Driving Pharmacogenomics Implementation Into Everyday Healthcare. Pharmacogenomics and Personalized Medicine 12, pages 305-318.
Read now
Read now
Ramón Cacabelos, Natalia Cacabelos & Juan C. Carril. (2019) The role of pharmacogenomics in adverse drug reactions. Expert Review of Clinical Pharmacology 12:5, pages 407-442.
Read now
Read now
Articles from other publishers (31)
Serena Mitaly, Jessica Wright, Razan El Melik & Eric Matey. (2023) Pharmacists’ role in supporting the return of over 10,000 preemptive pharmacogenomics results: The Mayo Clinic experience. American Journal of Health-System Pharmacy 80:23, pages 1733-1742.
Crossref
Crossref
Carlo Maria Bellanca, Egle Augello, Anna Flavia Cantone, Rosaria Di Mauro, Giuseppe Antonino Attaguile, Vincenza Di Giovanni, Guido Attilio Condorelli, Giulia Di Benedetto, Giuseppina Cantarella & Renato Bernardini. (2023) Insight into Risk Factors, Pharmacogenetics/Genomics, and Management of Adverse Drug Reactions in Elderly: A Narrative Review. Pharmaceuticals 16:11, pages 1542.
Crossref
Crossref
Nadine de Godoy Torso, Paulo Caleb JL Santos & Patricia Moriel. (2023) Challenges for the application of pharmacogenomics associated with the nomenclature of allelic variants. Pharmacogenomics 24:15, pages 793-796.
Crossref
Crossref
Charlene L Preys, Carrie L Blout Zawatsky, Amanda Massmann, Joel Van Heukelom, Robert C Green, Catherine Hajek, Madison R Hickingbotham, Emilie S Zoltick, April Schultz & Kurt D Christensen. (2023) Attitudes about pharmacogenomic testing vary by healthcare specialty. Pharmacogenomics 24:10, pages 539-549.
Crossref
Crossref
Varsha Singh. (2023) Current challenges and future implications of exploiting the omics data into nutrigenetics and nutrigenomics for personalized diagnosis and nutrition-based care. Nutrition 110, pages 112002.
Crossref
Crossref
Courtney Paetznick, David Gregornik, Lane Miller, Damon Olson & Jacob Brown. (2022) Implementation of a Clinical Pharmacogenomics Service in a Large Freestanding Pediatric Health System. Advances in Molecular Pathology 5:1, pages 119-129.
Crossref
Crossref
Evangelia Eirini Tsermpini, Zeina N. Al-Mahayri, Bassam R. Ali & George P. Patrinos. (2021) Clinical implementation of drug metabolizing gene-based therapeutic interventions worldwide. Human Genetics 141:6, pages 1137-1157.
Crossref
Crossref
Jaime L. Lopes, Kimberley Harris, Mary Beth Karow, Sandra E. Peterson, Michelle L. Kluge, Katrina E. Kotzer, Guilherme S. Lopes, Nicholas B. Larson, Suzette J. Bielinski, Steven E. Scherer, Liewei Wang, Richard M. Weinshilboum, John L. BlackIIIIII & Ann M. Moyer. (2022) Targeted Genotyping in Clinical Pharmacogenomics. The Journal of Molecular Diagnostics 24:3, pages 253-261.
Crossref
Crossref
Weifeng Qin, Xudong Lu, Qiang Shu, Huilong Duan & Haomin Li. (2022) Building an information system to facilitate pharmacogenomics clinical translation with clinical decision support. Pharmacogenomics 23:1, pages 35-48.
Crossref
Crossref
Ann M. Moyer & Pedro J. Caraballo. 2022. Comprehensive Pharmacology. Comprehensive Pharmacology
220
246
.
Ramón Cacabelos, Vinogran Naidoo, Lola Corzo, Natalia Cacabelos & Juan C. Carril. (2021) Genophenotypic Factors and Pharmacogenomics in Adverse Drug Reactions. International Journal of Molecular Sciences 22:24, pages 13302.
Crossref
Crossref
Maria-Theodora Pandi, Maria Koromina, Iordanis Tsafaridis, Sotirios Patsilinakos, Evangelos Christoforou, Peter J. van der Spek & George P. Patrinos. (2021) A novel machine learning-based approach for the computational functional assessment of pharmacogenomic variants. Human Genomics 15:1.
Crossref
Crossref
Dana M. Harris, Fernando F. Stancampiano, M. Caroline Burton, Ann M. Moyer, Michael J. Schuh, Jose R. Valery & Yan Bi. (2021) Use of Pharmacogenomics to Guide Proton Pump Inhibitor Therapy in Clinical Practice. Digestive Diseases and Sciences 66:12, pages 4120-4127.
Crossref
Crossref
Susanne B. Haga. (2021) Revisiting Secondary Information Related to Pharmacogenetic Testing. Frontiers in Genetics 12.
Crossref
Crossref
Rocío Rosas-Alonso, Javier Queiruga, Pedro Arias, Álvaro del Monte, Fernando Yuste, Carlos Rodríguez-Antolín, Itsaso Losantos-Garcia, Alberto M. Borobia & Sonia Rodríguez-Nóvoa. (2021) Analytical validation of a laboratory-development multigene pharmacogenetic assay. Pharmacogenetics and Genomics 31:8, pages 177-184.
Crossref
Crossref
Chengxian Guo, Biwen Hu, Chengjun Guo, Xiangguang Meng, Yun Kuang, Longjian Huang, Danling Wang, Kangwei Xu, Yanlin Zhao, Guoping Yang, Weimin Cai & Yan Shu. (2021) A Survey of Pharmacogenomics Testing Among Physicians, Pharmacists, and Researchers From China. Frontiers in Pharmacology 12.
Crossref
Crossref
Ina Liko, Lisa Corbin, Eric Tobin, Christina L Aquilante & Yee Ming Lee. (2021) Implementation of a pharmacist-provided pharmacogenomics service in an executive health program. American Journal of Health-System Pharmacy 78:12, pages 1094-1103.
Crossref
Crossref
Sze Ling Chan, Hariz Zhen Wei Liew, Francis Nguyen, Julian Thumboo, Wan Cheng Chow & Cynthia Sung. (2020) Prescription patterns of outpatients and the potential of multiplexed pharmacogenomic testing. British Journal of Clinical Pharmacology 87:3, pages 886-894.
Crossref
Crossref
Anthony J. Rothschild, Sagar V. Parikh, Daniel Hain, Rebecca Law, Michael E. Thase, Boadie W. Dunlop, Charles DeBattista, Charles R. Conway, Brent P. Forester, Richard C. Shelton, Matthew Macaluso, Krystal Brown, David Lewis, Alexander Gutin, Michael R. Jablonski & John F. Greden. (2021) Clinical validation of combinatorial pharmacogenomic testing and single-gene guidelines in predicting psychotropic medication blood levels and clinical outcomes in patients with depression. Psychiatry Research 296, pages 113649.
Crossref
Crossref
Amina M. Bagher, Thikryat Neamatallah, Ghadeer Balto, Lina Almikhy, Sara S. Almutairi, Mohammed O. Abushal, Khlood Baghlaf & Sara M. Bagher. (2021) Knowledge, perception, and confidence of hospital pharmacists toward pharmacogenetics in Jeddah, Kingdom of Saudi Arabia. Saudi Pharmaceutical Journal 29:1, pages 53-58.
Crossref
Crossref
Kristina A. Malsagova, Tatyana V. Butkova, Arthur T. Kopylov, Alexander A. Izotov, Natalia V. Potoldykova, Dmitry V. Enikeev, Vagarshak Grigoryan, Alexander Tarasov, Alexander A. Stepanov & Anna L. Kaysheva. (2020) Pharmacogenetic Testing: A Tool for Personalized Drug Therapy Optimization. Pharmaceutics 12:12, pages 1240.
Crossref
Crossref
Li He, Shaojun Chen, Jingao Li, Xiaoxue Xie, Lihua Huang, Yun Kuang, Kangwei Xu, Wanxia Huang, Yanling Zhao, Guoping Yang & Chengxian Guo. (2020) Genetic and phenotypic frequency distribution of CYP2C9, CYP2C19 and CYP2D6 in over 3200 Han Chinese. Clinical and Experimental Pharmacology and Physiology.
Crossref
Crossref
Aisling R. Caffrey & Eric P. Borrelli. (2021) The art and science of drug titration. Therapeutic Advances in Drug Safety 11, pages 204209862095891.
Crossref
Crossref
David Bick, Marilyn Jones, Stacie L Taylor, Ryan J Taft & John Belmont. (2019) Case for genome sequencing in infants and children with rare, undiagnosed or genetic diseases. Journal of Medical Genetics 56:12, pages 783-791.
Crossref
Crossref
Ann M. Moyer & Linnea M. Baudhuin. (2019) Consumer-initiated Genetic Testing and Pharmacogenomics. Advances in Molecular Pathology 2:1, pages 133-142.
Crossref
Crossref
Ambily Sivadas & Vinod Scaria. 2019.
119
161
.
Mohamad M. Kronfol & Joseph L. McClay. 2019. Prognostic Epigenetics. Prognostic Epigenetics
375
395
.
Geoffrey S. Ginsburg & Susanne B. Haga. 2019. Emery and Rimoin's Principles and Practice of Medical Genetics and Genomics. Emery and Rimoin's Principles and Practice of Medical Genetics and Genomics
21
45
.
María Luisa Romero Lagunes & Francisco Emilio Vera Badillo. 2019. Translational Research and Onco-Omics Applications in the Era of Cancer Personal Genomics. Translational Research and Onco-Omics Applications in the Era of Cancer Personal Genomics
43
77
.
Aniwaa Owusu Obeng, Kezhen Fei, Kenneth Levy, Amanda Elsey, Toni Pollin, Andrea Ramirez, Kristin Weitzel & Carol Horowitz. (2018) Physician-Reported Benefits and Barriers to Clinical Implementation of Genomic Medicine: A Multi-Site IGNITE-Network Survey. Journal of Personalized Medicine 8:3, pages 24.
Crossref
Crossref
Amy A Lemke, Peter J Hulick, Dyson T Wake, Chi Wang, Annette W Sereika, Kristen Dilzell Yu, Nicole S Glaser & Henry M Dunnenberger. (2018) Patient perspectives following pharmacogenomics results disclosure in an integrated health system. Pharmacogenomics 19:4, pages 321-331.
Crossref
Crossref